Your Chance to Buy Dividend Machines on the Cheap
Companies / Dividends Sep 22, 2011 - 12:47 PMBy: DailyWealth
Dr. David Eifrig writes: Steve Sjuggerud didn't highlight it, but he's onto a terrific idea for income investors right now...
Last Wednesday, Steve showed you how several market sectors are incredible values right now. In some cases, these values are at 20-year extremes.
Some of my favorite values right now are the companies contained in the "RXL" fund Steve covered. "RXL" is the symbol for the ProShares Ultra Health Care Fund. It's a basket of the world's biggest health care companies. Most of the fund consists of Big Pharma stocks.
For folks interested in investment income, this is key...
Much of the time, Big Pharma stocks are great income investments. The best Big Pharma stocks have fat profit margins... and they sell products that many of their customers can't live without. This allows them to pass large amounts of cash on to their shareholders in the form of dividends.
As Tom Dyson highlighted in DailyWealth, Big Pharma stocks are among the market's strongest, steadiest performers over the long term.
And right now, some of my favorite Big Pharma stocks – which I've recommended in my Retirement Millionaire letter – are great values right now.
Abbott Laboratories, for example, is a large and diversified health care company. Buying Abbott is almost like getting five different companies... It's divided into four segments – pharmaceutical, diagnostic, nutritional, and vascular – plus an assortment of businesses involved in diabetes and eye care (both surgical care, like LASIK and cataract removal, and consumer products, like contact lenses and eye drops).
Abbott is a classic Retirement Millionaire mix of safety and income. The company can grow sales during difficult economic times. In the past five years, it's grown net sales 38%, from $22.3 billion to $30.8 billion.
It rewards shareholders and has increased its dividend for the past 38 years. Right now, Abbott has a dividend of 3.7%. And it's currently trading for just 2.2 times sales... That makes it even cheaper than when I recommended it to my readers in February.
Eli Lilly is another great example of a Big Pharma stock you should be investing in. Lilly is the world's 10th-largest pharmaceutical company and has a long history of producing major blockbuster drugs (like Cymbalta or Cialis). And Lilly's success has translated into a steady income stream for investors.
It has a 125-year history of paying its dividend and a string of 42 consecutive annual increases. Its dividend is growing at around 7.5% a year. And right now, it yields 5.2%.
Lilly's stock has taken a big hit in the last few years – down from $60 five years ago to around $38 today... Yet, it's making nearly 50% more money today than it did back in 2007. This means we're paying much less for the same dollar of earnings than we would have three years ago.
Big Pharma stocks are among the best stocks in the world at safely growing your money and paying dividends. They have a terrific tailwind at their back with the Baby Boomer generation growing older. And right now, they're a great deal.
Here's to our health, wealth, and a great retirement,
Doc Eifrig
Editor's note: Dr. David Eifrig is the editor of Retirement Millionaire, a monthly publication that shows folks at or near retirement how to maximize the income they make on their portfolios, pay 25%-50% less for just about everything, and drastically reduce their medical bills. For his latest idea, one that could save your retirement in the next five years, click here.
The DailyWealth Investment Philosophy: In a nutshell, my investment philosophy is this: Buy things of extraordinary value at a time when nobody else wants them. Then sell when people are willing to pay any price. You see, at DailyWealth, we believe most investors take way too much risk. Our mission is to show you how to avoid risky investments, and how to avoid what the average investor is doing. I believe that you can make a lot of money – and do it safely – by simply doing the opposite of what is most popular.
Customer Service: 1-888-261-2693 – Copyright 2011 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202
Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.
Daily Wealth Archive
|
© 2005-2012 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.
Comments
Post Comment (Moderated)